It is used for the treatment of pancreatitis in
Japan and also was found to prevent SARS-CoV-2 cell entry in
vitro through inhibition of the host serine protease, TMPRSS2. This
novel mechanism provides an additional drug target for future research
(Hoffmann et al., 2020).